CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Biofrontera AG Company Snapshot
Biofrontera AG operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Biofrontera AG with three other miscellaneous service companies in Europe: Oryzon Genomics Sa of Spain (2015 sales of 4.25 million Euro [US$4.50 million] ), Biotie Therapies Corp of Finland (3.74 million Euro [US$3.95 million] of which 100% was F. Hoffman La Roche), and Genfit which is based in France (4.36 million Euro [US$4.61 million] of which 100% was Therapeutic Drugs).

Sales Analysis. Biofrontera AG reported sales of 4.14 million Euro (US$4.38 million) for the year ending December of 2015. This represents an increase of 33.7% versus 2014, when the company's sales were 3.10 million Euro.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Biofrontera AG
  Stock Performance Chart for Biofrontera AG
 
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 3.26
(Figures in Euro)
1 Week 3.8%   13 Weeks 4.9%  
4 Weeks 11.6%   52 Weeks 72.4%  
 
Biofrontera AG Key Data:
  Ticker: B8F Country: Germany
  Exchanges: FRA LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2015 Sales 4,137,917
(Year Ending Jan 2016).
Employees: 58
  Currency: Euro Market Cap: 98,933,870
  Fiscal Yr Ends: December Shares Outstanding: 30,347,813
  Share Type: Stammaktie Closely Held Shares: 13,268,873
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.